Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, AŞ Message Board

  • eastcoasttroll eastcoasttroll Aug 21, 2009 12:46 PM Flag

    Take a look at Insider holdings

     

    http://www.secform4.com/insider-trading/1142576.htm

    They are loaded.

    From the 8K 8/5/09...
    <<< Optimer reported a net loss for the second quarter of 2009 of $12.4 million, or $0.37 per share, which was in line with the Company’s expectations. This compares to a net loss for the second quarter of 2008 of $8.1 million, or $0.29 per share. The increase in net loss was primarily due to higher research and development expenses. Research and development expenses in the second quarter of 2009 were $10.5 million, compared to $6.2 million in the second quarter of 2008. The increase was primarily due to manufacturing scale-up expenses and expenses to prepare regulatory filings related to the Company’s fidaxomicin and prulifloxacin programs.

    As of June 30, 2009, Optimer held cash, cash equivalents and short-term investments of $51.2 million.>>>

    Repeat: "The increase was primarily due to manufacturing scale-up expenses and expenses to prepare regulatory filings related to the Company’s fidaxomicin and prulifloxacin programs."

    It never happens that they file and get approval the next day. They may be told to add another test, etc.,etc., but approval will be down the road. The regulatory filing will provide a pop in PPS.

    This topic is deleted.